Exro ($EXROF) secures $30M lifeline to keep lights on during strategic review. Key catch: Needs debentureholders to take backseat on collateral. Warrants for 75M shares pending TSX nod. Survival mode continues as they hunt for M&A or partnerships. High-stakes poker with creditors.
https://www.prnewswire.com/news-releases/exro-announces-us30-million-credit-facility-plan-to-seek-debentureholder-consent-and-strategic-review-process-302457464.html
$EXROF Q1 2025 shows explosive revenue growth ($4.44M vs $87k YoY) but the balance sheet is flashing red. Cash down to $760k with a $7M working capital deficit. Strategic moves (20% workforce cut, APAC wind-down) may help, but liquidity crisis looms. Bulls will note OEM traction; bears see a race against time.
https://www.prnewswire.com/news-releases/exro-technologies-reports-first-quarter-2025-results-302457321.html
